Literature DB >> 27547713

MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis.

Christine Roden1, Jun Lu2.   

Abstract

Studies on hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) have helped to establish the paradigms of normal and cancer stem cell concepts. For both HSCs and LSCs, specific gene expression programs endowed by their epigenome functionally distinguish them from their differentiated progenies. MicroRNAs (miRNAs), as a class of small non-coding RNAs, act to control post-transcriptional gene expression. Research in the past decade has yielded exciting findings elucidating the roles of miRNAs in control of multiple facets of HSC and LSC biology. Here we review recent progresses on the functions of miRNAs in HSC emergence during development, HSC switch from a fetal/neonatal program to an adult program, HSC self-renewal and quiescence, HSC aging, HSC niche, and malignant stem cells. While multiple different miRNAs regulate a diverse array of targets, two common themes emerge in HSC and LSC biology: miRNA mediated regulation of epigenetic machinery and cell signaling pathways. In addition, we propose that miRNAs themselves behave like epigenetic regulators, as they possess key biochemical and biological properties that can provide both stability and alterability to the epigenetic program. Overall, the studies of miRNAs in stem cells in the hematologic contexts not only provide key understandings to post-transcriptional gene regulation mechanisms in HSCs and LSCs, but also will lend key insights for other stem cell fields.

Entities:  

Keywords:  epigenetic machinery; hematopoietic stem cells; leukemia stem cells; miRNAs

Year:  2016        PMID: 27547713      PMCID: PMC4988405          DOI: 10.1007/s40778-016-0057-1

Source DB:  PubMed          Journal:  Curr Stem Cell Rep


  169 in total

1.  Macrophage development from HSCs requires PU.1-coordinated microRNA expression.

Authors:  Saeed Ghani; Pia Riemke; Jörg Schönheit; Dido Lenze; Jürgen Stumm; Maarten Hoogenkamp; Anne Lagendijk; Sven Heinz; Constanze Bonifer; Jeroen Bakkers; Salim Abdelilah-Seyfried; Michael Hummel; Frank Rosenbauer
Journal:  Blood       Date:  2011-07-05       Impact factor: 22.113

2.  A systems biology approach for defining the molecular framework of the hematopoietic stem cell niche.

Authors:  Pierre Charbord; Claire Pouget; Hans Binder; Florent Dumont; Grégoire Stik; Pacifique Levy; Fabrice Allain; Céline Marchal; Jenna Richter; Benjamin Uzan; Françoise Pflumio; Franck Letourneur; Henry Wirth; Elaine Dzierzak; David Traver; Thierry Jaffredo; Charles Durand
Journal:  Cell Stem Cell       Date:  2014-07-17       Impact factor: 24.633

3.  MicroRNA miR-125b causes leukemia.

Authors:  Marina Bousquet; Marian H Harris; Beiyan Zhou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

4.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

5.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

6.  Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells.

Authors:  Ilango Balakrishnan; Xiaodong Yang; Joseph Brown; Aravind Ramakrishnan; Beverly Torok-Storb; Peter Kabos; Jay R Hesselberth; Manoj M Pillai
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

7.  MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.

Authors:  Ramiro Garzon; Stefano Volinia; Chang-Gong Liu; Cecilia Fernandez-Cymering; Tiziana Palumbo; Flavia Pichiorri; Muller Fabbri; Kevin Coombes; Hansjuerg Alder; Tatsuya Nakamura; Neal Flomenberg; Guido Marcucci; George A Calin; Steven M Kornblau; Hagop Kantarjian; Clara D Bloomfield; Michael Andreeff; Carlo M Croce
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.

Authors:  Ute Bissels; Stefan Wild; Stefan Tomiuk; Markus Hafner; Hartmut Scheel; Aleksandra Mihailovic; Yeong-Hoon Choi; Thomas Tuschl; Andreas Bosio
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

10.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Authors:  N Gefen; V Binder; M Zaliova; Y Linka; M Morrow; A Novosel; L Edry; L Hertzberg; N Shomron; O Williams; J Trka; A Borkhardt; S Izraeli
Journal:  Leukemia       Date:  2009-11-05       Impact factor: 11.528

View more
  10 in total

1.  Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.

Authors:  Giovannino Silvestri; Rossana Trotta; Lorenzo Stramucci; Justin J Ellis; Jason G Harb; Paolo Neviani; Shuzhen Wang; Ann-Kathrin Eisfeld; Christopher J Walker; Bin Zhang; Klara Srutova; Carlo Gambacorti-Passerini; Gabriel Pineda; Catriona H M Jamieson; Fabio Stagno; Paolo Vigneri; Georgios Nteliopoulos; Philippa C May; Alistair G Reid; Ramiro Garzon; Denis-Claude Roy; Moutuaata M Moutuou; Martin Guimond; Peter Hokland; Michael W Deininger; Garrett Fitzgerald; Christopher Harman; Francesco Dazzi; Dragana Milojkovic; Jane F Apperley; Guido Marcucci; Jianfei Qi; Katerina Machova Polakova; Ying Zou; Xiaoxuan Fan; Maria R Baer; Bruno Calabretta; Danilo Perrotti
Journal:  Blood Cancer Discov       Date:  2020-07

2.  miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.

Authors:  Jun Liu; Bo Guo; Zhuo Chen; Nayi Wang; Michelina Iacovino; Jijun Cheng; Christine Roden; Wen Pan; Sajid Khan; Suning Chen; Michael Kyba; Rong Fan; Shangqin Guo; Jun Lu
Journal:  Blood       Date:  2017-01-04       Impact factor: 22.113

3.  miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.

Authors:  Xiaodong Guo; Ling Yu; Zhengpei Zhang; Guo Dai; Tian Gao; Weichun Guo
Journal:  Cancer Cell Int       Date:  2017-02-17       Impact factor: 5.722

Review 4.  MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Authors:  Stefania Trino; Daniela Lamorte; Antonella Caivano; Ilaria Laurenzana; Daniela Tagliaferri; Geppino Falco; Luigi Del Vecchio; Pellegrino Musto; Luciana De Luca
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

5.  Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells.

Authors:  Ilaria Laurenzana; Stefania Trino; Daniela Lamorte; Angelo De Stradis; Michele Santodirocco; Alessandro Sgambato; Luciana De Luca; Antonella Caivano
Journal:  Front Med (Lausanne)       Date:  2021-12-16

6.  MiRNA-142-3p increases radiosensitivity in human umbilical cord blood mononuclear cells by inhibiting the expression of CD133.

Authors:  Fang Yuan; Lu Liu; Yonghong Lei; Yi Hu
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

7.  Identification of osteolineage cell-derived extracellular vesicle cargo implicated in hematopoietic support.

Authors:  Jess Morhayim; Corina A Ghebes; Stefan J Erkeland; Mariëtte N D Ter Borg; Remco M Hoogenboezem; Eric M J Bindels; Floris P J van Alphen; Moustapha Kassem; Andre J van Wijnen; Jan J Cornelissen; Johannes P van Leeuwen; Bram C J van der Eerden; Carlijn Voermans; Jeroen van de Peppel; Eric Braakman
Journal:  FASEB J       Date:  2020-02-21       Impact factor: 5.191

Review 8.  MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.

Authors:  Florentina Duică; Carmen Elena Condrat; Cezara Alina Dănila; Andreea Elena Boboc; Mihaela Raluca Radu; Junjie Xiao; Xinli Li; Sanda Maria Creţoiu; Nicolae Suciu; Dragoş Creţoiu; Dragoş-Valentin Predescu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

9.  MicroRNA-21 maintains hematopoietic stem cell homeostasis through sustaining the NF-κB signaling pathway in mice.

Authors:  Mengjia Hu; Yukai Lu; Hao Zeng; Zihao Zhang; Shilei Chen; Yan Qi; Yang Xu; Fang Chen; Yong Tang; Mo Chen; Changhong Du; Mingqiang Shen; Fengchao Wang; Yongping Su; Song Wang; Junping Wang
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

10.  The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin's Lymphomas.

Authors:  Yuliya A Veryaskina; Sergei E Titov; Igor B Kovynev; Tatiana I Pospelova; Igor F Zhimulev
Journal:  Diagnostics (Basel)       Date:  2022-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.